BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-16.77%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$140M
AUM Growth
+$140M
(-19%)
Cap. Flow
-$9.74K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
90.94%
Holding
43
New
3
Increased
9
Reduced
4
Closed
3
Top Buys
| 1 |
Collegium Pharmaceutical
COLL
|
$327K |
| 2 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$302K |
| 3 |
AXDX
Accelerate Diagnostics
AXDX
|
$287K |
| 4 |
CELG
Celgene Corp
CELG
|
$270K |
| 5 |
Pacific Biosciences
PACB
|
$230K |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$644K |
| 2 |
PTC Therapeutics
PTCT
|
$483K |
| 3 |
Gilead Sciences
GILD
|
$387K |
| 4 |
Cerus
CERS
|
$335K |
| 5 |
Agios Pharmaceuticals
AGIO
|
$221K |
Sector Composition
| 1 | Healthcare | 91.79% |
| 2 | Energy | 3.24% |
| 3 | Consumer Staples | 2.76% |
